Gallage, Suchira http://orcid.org/0000-0002-1956-3597
Irvine, Elaine E.
Barragan Avila, Jose Efren http://orcid.org/0000-0002-9348-909X
Reen, Virinder
Pedroni, Silvia M. A.
Duran, Imanol http://orcid.org/0000-0001-6615-3788
Ranvir, Vikas http://orcid.org/0000-0002-0437-6908
Khadayate, Sanjay http://orcid.org/0000-0003-4278-6403
Pombo, Joaquim
Brookes, Sharon
Heide, Danijela
Dharmalingham, Gopuraja
Choudhury, Agharul I.
Singh, Indrabahadur
Herranz, Nicolás
Vernia, Santiago http://orcid.org/0000-0001-6728-5555
Heikenwalder, Mathias http://orcid.org/0000-0002-3135-2274
Gil, Jesús http://orcid.org/0000-0002-4303-6260
Withers, Dominic J. http://orcid.org/0000-0002-8009-7521
Article History
Received: 14 November 2022
Accepted: 30 July 2024
First Online: 29 August 2024
Competing interests
: J.G. has been a consultant for Unity Biotechnology, Geras Bio, Myricx Pharma and Merck KGaA. Pfizer and Unity Biotechnology have funded research in J.G.’s laboratory (unrelated to the work presented here). J.G. owns equity in Geras Bio. J.G. is a named inventor in Medical Research Council and Imperial College patents, both related to senolytic therapies (the patents are not related to the work presented here). The remaining authors declare no competing interests.